Table 1 Baseline characteristics of the studied patients on admission.
From: Fluid restriction management in the treatment of COVID-19: a single-center observational study
Group 1 (N = 48) | Group 2 (N = 43) | Group 3 (N = 25) | |
---|---|---|---|
Age, years | 58 (47–70) | 65 (53–71.5) | 56 (51–62) |
Male, n (%) | 40 (83.3) | 31 (72.1) | 19 (76.0) |
Transfer, n (%) | 26 (54.2) | 33 (76.7) | 20 (80) |
Height, cm | 171 (163–178) | 167 (160–170) | 166 (160–171) |
Weight, kg | 76.4 (66.25–90.5) | 70 (59–82.6) | 83.4 (73.2–100) |
BMI, kg/m2 | 26 (23.1–30.2) | 27.1 (22.7–31.1) | 31.5 (27.1–33.1) |
Lactate, mmol/L | 1.5 (1.15–1.85) | 1.45 (1.2–1.95) | 1.5 (1.1–1.9) |
WBC, /103μL | 6.3 (4.9–8.95) | 7.4 (4.7–10.7) | 8.5 (5.8–12.7) |
Hb, g/dL | 14.4 (13–15.3) | 13.4 (12.75–14.4) | 14.1 (12.9–14.9) |
Ht, % | 41.4 (38.3–44.2) | 39.5 (36.8–42.1) | 40.8 (37.9–42.6) |
Plt, /103μL | 199 (168–249) | 217 (154–253) | 208 (171–257) |
Neu, % | 82.1 (74.2–87.4) | 87.5 (83.1–91.6) | 87.7 (82.5–91.5) |
Lym, % | 12.6 (8.6–20) | 8.3 (4.4–13.7) | 9.3 (5.7–13.2) |
Mo, % | 4.5 (3.1–6.2) | 2.9 (2.2–5) | 3 (2–5.2) |
Eo, % | 0.1 (0–0.3) | 0 (0–0) | 0 (0–0) |
Ba, % | 0.1 (0.1–0.2) | 0.1 (0.1–0.2) | 0.2 (0.1–0.2) |
Glucose, mg/dL | 142 (117–164.5) | 179 (144.5–220.5) | 181 (131–209) |
TP, g/dL | 6.5 (6–6.9) | 6.2 (5.9–6.7) | 6.2 (5.9–6.7) |
Albumin, g/dL | 3.2 (2.9–3.6) | 2.8 (2.7–2.9) | 2.9 (2.6–3.2) |
BUN, mg/dL | 16 (13–20) | 20 (17–31) | 22 (15–29) |
Creatinine, mg/dL | 0.8 (0.7–0.95) | 0.8 (0.6–1.1) | 0.8 (0.6–1.3) |
T-bil, mg/dL | 0.6 (0.5–0.8) | 0.6 (0.45–0.8) | 0.7 (0.4–1.2) |
CRP, mg/dL | 4.39 (2.5–11.75) | 7.99 (3.45–15.6) | 13.09 (4.64–17.85) |
CK, /UL | 99 (57–163) | 103 (53–241) | 334 (102–452) |
HbA1c, % | 6.5 (6–7.7) | 6.6 (6.1–7.6) | 6.7 (6.4–7.3) |
Mg, mg/dL | 2.2 (2–2.3) | 2.2 (2–2.35) | 2.2 (1.9–2.3) |
IP, mg/dL | 3 (2.6–3.5) | 3.6 (3–4.35) | 3.4 (2.6–4.2) |
Ferritin, ng/mL | 762.3 (392.1–1400.2) | 1156.2 (607.6–1526.7) | 1052.7 (598.7–1666.8) |
PT-INR | 1.02 (0.97–1.18) | 1.06 (1.02–1.14) | 1.06 (1.01–1.13) |
APTT, s | 30.8 (28.9–34.7) | 34.8 (30.1–44.1) | 33 (28.7–44.5) |
Fibrinogen, mg/dL | 543 (468–606) | 579 (478–678) | 602 (504–686) |
d-Dimer, μg/mL | 2.1 (1.8–2.9) | 2.7 (2.1–3.9) | 3 (2.3–6.3) |